get a key
steadybase-$ company KAPA
account_id none on file
legal_name Kairos Pharma, LTD.
ticker KAPA
cik 1962011
domain kairospharma.com
entry_point_account_id none on file
name Kairos Pharma Ltd.
exchange NYSE
sector Health Care
calls 0 filings 2 executives 1 family 0
why_nownone on file
callsnone on file
filings
insurance costs; administrative travel expenses; marketing expenses and other operating costs. We anticipate that our general and administrative expenses will increase in the future as we increase our headcount to support our business operations.

filing / Aug 12, 2026 / receipt

to as “householding,” can result in significant cost savings for us. To take advantage of this opportunity, the Company and

filing / May 22, 2026 / receipt

executives
Rahul Singhvi director - receipt
familynone on file
upcoming
2026-11-13 earnings call scheduled ir
changes
2024-12-13 director, appointed sec_8k
mcp_package_hint
steadybase-$